- Home
- ERAS vs CLNE Comparison
ERAS vs CLNE Comparison
Compare ERAS & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- CLNE
- Stock Information
- Founded
- ERAS 2018
- CLNE 2001
- Country
- ERAS United States
- CLNE United States
- Employees
- ERAS N/A
- CLNE N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- CLNE Natural Gas Distribution
- Sector
- ERAS Health Care
- CLNE Utilities
- Exchange
- ERAS Nasdaq
- CLNE Nasdaq
- Market Cap
- ERAS 723.8M
- CLNE 692.6M
- IPO Year
- ERAS 2021
- CLNE 2007
- Fundamental
- Price
- ERAS $2.47
- CLNE $2.67
- Analyst Decision
- ERAS Strong Buy
- CLNE Strong Buy
- Analyst Count
- ERAS 5
- CLNE 4
- Target Price
- ERAS $5.90
- CLNE $5.38
- AVG Volume (30 Days)
- ERAS 1.2M
- CLNE 1.9M
- Earning Date
- ERAS 11-12-2024
- CLNE 11-06-2024
- Dividend Yield
- ERAS N/A
- CLNE N/A
- EPS Growth
- ERAS N/A
- CLNE N/A
- EPS
- ERAS N/A
- CLNE N/A
- Revenue
- ERAS N/A
- CLNE $413,396,000.00
- Revenue This Year
- ERAS N/A
- CLNE N/A
- Revenue Next Year
- ERAS N/A
- CLNE $1.69
- P/E Ratio
- ERAS N/A
- CLNE N/A
- Revenue Growth
- ERAS N/A
- CLNE N/A
- 52 Week Low
- ERAS $1.64
- CLNE $2.17
- 52 Week High
- ERAS $3.45
- CLNE $4.13
- Technical
- Relative Strength Index (RSI)
- ERAS 42.73
- CLNE 41.97
- Support Level
- ERAS $2.51
- CLNE $2.65
- Resistance Level
- ERAS $2.68
- CLNE $2.80
- Average True Range (ATR)
- ERAS 0.21
- CLNE 0.13
- MACD
- ERAS -0.04
- CLNE -0.01
- Stochastic Oscillator
- ERAS 14.56
- CLNE 9.43
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About CLNE Clean Energy Fuels Corp.
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas, and renewable natural gas as an alternative fuel for vehicles. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.